Literature DB >> 23211319

Early metabolic defects in Arab subjects with strong family history of Type 2 diabetes.

A Shalata1, W Jazmawi, O Aslan, K Badarni, K Dabbah, S Sawaed, O Cohen Castel, Z U Borochowitz, K Karkabi, R Defronzo, M Abdul-Ghani.   

Abstract

AIMS AND
OBJECTIVE: It is widely accepted that the genetic make-up of the subject plays a pivotal role in the development of insulin resistance and β cell failure. The objective of this study was to examine whether the same or distinct genetic backgrounds contribute to the development of insulin resistance and β cell failure.
METHODS: We examined insulin sensitivity and β cell function in lean normal glucose tolerance subjects from 3 multigeneration Arab families. Families 1 and 2 had strong history of Type 2 diabetes (T2DM), while no member of family 3 had T2DM.
RESULTS: Subjects in family 1 manifested increased basal plasma free fatty acid (FFA) concentration and impaired suppression of plasma FFA during the OGTT compared to subjects in family 3. Subjects in family 2 had comparable fasting plasma FFA and suppression of plasma FFA during the OGTT to family 3. Both the absolute plasma glucose concentrations, and incremental area under the plasma glucose curve (ΔG0-120) during the OGTT were comparable in subjects of families 1 and 2, and were decreased in subjects of family 3. Whole body and muscle insulin sensitivity were comparable in subjects from families 2 and 3, and both were significantly decreased in subjects of family 1. Beta cell function was comparable in subjects of families 1 and 3 and was significantly decreased in subjects of family 2.
CONCLUSION: These results demonstrate that distinct genetic background contributes to the development of insulin resistance and β cell dysfunction in Arab individuals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23211319     DOI: 10.3275/8762

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.

Authors:  Muhammad A Abdul-Ghani; Christopher P Jenkinson; Dawn K Richardson; Devjit Tripathy; Ralph A DeFronzo
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

2.  The disposal of an oral glucose load in healthy subjects. A quantitative study.

Authors:  E Ferrannini; O Bjorkman; G A Reichard; A Pilo; M Olsson; J Wahren; R A DeFronzo
Journal:  Diabetes       Date:  1985-06       Impact factor: 9.461

3.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

Authors:  L C Groop; R C Bonadonna; S DelPrato; K Ratheiser; K Zyck; E Ferrannini; R A DeFronzo
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 4.  Pathogenesis of insulin resistance in skeletal muscle.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Biomed Biotechnol       Date:  2010-04-26

Review 5.  Pathophysiology of prediabetes.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

Review 6.  The emerging genetic architecture of type 2 diabetes.

Authors:  Alessandro Doria; Mary-Elizabeth Patti; C Ronald Kahn
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

7.  Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes.

Authors:  Sangeeta R Kashyap; Renata Belfort; Rachele Berria; Swangjit Suraamornkul; Thongchai Pratipranawatr; Jean Finlayson; Andrea Barrentine; Mandeep Bajaj; Lawrence Mandarino; Ralph DeFronzo; Kenneth Cusi
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-05-04       Impact factor: 4.310

8.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.

Authors:  Kitt Falk Petersen; Sylvie Dufour; Douglas Befroy; Rina Garcia; Gerald I Shulman
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

Review 9.  Pathogenesis of type 2 diabetes mellitus.

Authors:  Ralph A DeFronzo
Journal:  Med Clin North Am       Date:  2004-07       Impact factor: 5.456

10.  Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.

Authors:  W Pimenta; M Korytkowski; A Mitrakou; T Jenssen; H Yki-Jarvinen; W Evron; G Dailey; J Gerich
Journal:  JAMA       Date:  1995-06-21       Impact factor: 56.272

View more
  2 in total

Review 1.  Literature review of type 2 diabetes mellitus among minority Muslim populations in Israel.

Authors:  Yulia Treister-Goltzman; Roni Peleg
Journal:  World J Diabetes       Date:  2015-02-15

2.  Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm.

Authors:  Muhammad Abdul-Ghani; Ralph A DeFronzo
Journal:  Diabetes Care       Date:  2017-08       Impact factor: 19.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.